NOLAZOL Trademark

Trademark Overview

On Wednesday, July 6, 2016, a trademark application was filed for NOLAZOL with the United States Patent and Trademark Office. The USPTO has given the NOLAZOL trademark a serial number of 79191835. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 26, 2024. This trademark is owned by NLS-1 Pharma AG. The NOLAZOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations targeting the human central nervous system
nolazol

General Information

Serial Number79191835
Word MarkNOLAZOL
Filing DateWednesday, July 6, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 26, 2024
Registration Number5238684
Registration DateTuesday, July 11, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations targeting the human central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNLS Pharmaceutics AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH
Party NameNLS-1 Pharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNLS-1 Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNLS-1 Pharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, November 11, 2016REFUSAL PROCESSED BY IB
Thursday, September 15, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 24, 2016APPLICATION FILING RECEIPT MAILED
Monday, October 17, 2016ASSIGNED TO EXAMINER
Wednesday, October 19, 2016NON-FINAL ACTION WRITTEN
Thursday, October 20, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 24, 2016REFUSAL PROCESSED BY MPU
Monday, October 24, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 5, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, April 22, 2017NOTIFICATION PROCESSED BY IB
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 11, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 19, 2017FINAL DISPOSITION PROCESSED
Monday, March 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, November 10, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 11, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 26, 2024CANCELLED SECTION 71
Friday, March 1, 2024NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 19, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 8, 2019CHANGE OF OWNER RECEIVED FROM IB
Friday, September 27, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 18, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 2, 2024INVALIDATION PROCESSED
Wednesday, October 2, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

nolazol nervous system central human preparations targeting pharmaceutical